Email updates

Keep up to date with the latest news and content from BMC Gastroenterology and BioMed Central.

Open Access Research article

Four novel mutations in the lactase gene (LCT) underlying congenital lactase deficiency (CLD)

Suvi Torniainen1, Roberta Freddara2, Taina Routi3, Carolien Gijsbers4, Carlo Catassi5, Pia Höglund6, Erkki Savilahti7 and Irma Järvelä16*

Author Affiliations

1 Department of Medical Genetics, University of Helsinki, Haartman Institute, Helsinki, Finland

2 Neonatal Intensive Care Division, "G. Salesi" Children Hospital, Ancona, Italy

3 Department of Paediatrics, Turku University Hospital, Turku, Finland

4 Juliana Children's Hospital/Haga Teaching Hospital, The Hague, The Netherlands

5 Department of Paediatrics, Università Politecnica delle Marche, Ancona, Italy

6 Helsinki University Hospital, Laboratory Services, Helsinki, Finland

7 Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland

For all author emails, please log on.

BMC Gastroenterology 2009, 9:8  doi:10.1186/1471-230X-9-8

Published: 22 January 2009

Abstract

Background

Congenital lactase deficiency (CLD) is a severe gastrointestinal disorder of newborns. The diagnosis is challenging and based on clinical symptoms and low lactase activity in intestinal biopsy specimens. The disease is enriched in Finland but is also present in other parts of the world. Mutations encoding the lactase (LCT) gene have recently been shown to underlie CLD. The purpose of this study was to identify new mutations underlying CLD in patients with different ethnic origins, and to increase awareness of this disease so that the patients could be sought out and treated correctly.

Methods

Disaccharidase activities in intestinal biopsy specimens were assayed and the coding region of LCT was sequenced from five patients from Europe with clinical features compatible with CLD. In the analysis and prediction of mutations the following programs: ClustalW, Blosum62, PolyPhen, SIFT and Panther PSEC were used.

Results

Four novel mutations in the LCT gene were identified. A single nucleotide substitution leading to an amino acid change S688P in exon 7 and E1612X in exon 12 were present in a patient of Italian origin. Five base deletion V565fsX567 leading to a stop codon in exon 6 was found in one and a substitution R1587H in exon 12 from another Finnish patient. Both Finnish patients were heterozygous for the Finnish founder mutation Y1390X. The previously reported mutation G1363S was found in a homozygous state in two siblings of Turkish origin.

Conclusion

This is the first report of CLD mutations in patients living outside Finland. It seems that disease is more common than previously thought. All mutations in the LCT gene lead to a similar phenotype despite the location and/or type of mutation.